Company intelligence / Profile preview

Quantitative BioSciences

San Diego, California, United Statesqbisci.com ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

Quantitative BioSciences has developed a customizable, synthetic biology-driven platform that uses engineered microbial sensors paired with microfluidics to continuously monitor environmental contaminants such as PFASs. They have demonstrated technical feasibility by identifying nanobodies specific for PFOA/PFOS and integrating them into E. coli display systems within their multiplexed sensing devices. The technology enables sensitive, selective, and continuous monitoring of hazardous exposures in water supplies

Therapeutic areas: Other
Modalities: Single-domain antibody (VHH/nanobody)Engineered microbial sensor strainsMicrofluidic device-based biosensors
Industry: Non-Drug Biotech

Partnerships

Abcore (nanobody discovery partner)

Beyond the preview

Go deeper on Quantitative BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quantitative BioSciences.

Explore the full profile